Ventyx Biosciences, Inc. Passive Investment Disclosure (>5%)
Ventyx Biosciences reports that Glazer Capital and Paul J. Glazer collectively beneficially own 6.23% of common stock, representing 4,446,004 shares as reported.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ventyx Biosciences reports that Glazer Capital and Paul J. Glazer collectively beneficially own 6.23% of common stock, representing 4,446,004 shares as reported. The ownership is held through Glazer-managed funds, with shared voting and dispositive power over the shares.
The filing names Glazer Capital Enhanced Master Fund, Ltd. as a Glazer Fund that has the right to receive proceeds from the sale of more than 5% of the outstanding common stock. The statement is dated 02/12/2026 with signatures on 02/19/2026.
Insights
Glazer Capital reports a passive, material stake of 6.23% in Ventyx.
Glazer Capital and Paul J. Glazer are disclosed as reporting persons managing 4,446,004 shares with shared voting and dispositive power, indicating control exercised on behalf of Glazer-managed vehicles.
The filing identifies Glazer Capital Enhanced Master Fund, Ltd. as having the right to receive sale proceeds above 5%. Timing and planned dispositions are not stated; subsequent filings would show any trading activity.
Disclosure shows shared authority, not sole ownership, which is typical for manager-managed funds.
The report clarifies that voting and dispositive powers are shared for the disclosed 4,446,004 shares, and the Reporting Persons disclaim automatic attribution beyond managerial roles.
Beneficial ownership of 6.23% crosses the 5% materiality threshold that triggers Schedule 13G reporting; the filing lists the fund entitled to proceeds but does not state any planned sales.
AI-generated analysis. How Rhea-AI works. Not financial advice.